UPMC Late-Life Depression, Evaluation, Prevention, and Treatment Program is a clinical research site located in Pittsburgh, Pennsylvania, United States 15213.
Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.
UPMC Late-Life Depression, Evaluation, Prevention, and Treatment Program has participated in 3 clinical trials.
Therapeutic areas: Treatment Resistant Depression, Refractory Depression, Therapy-Resistant Depression.
Sponsors: Washington University School of Medicine, Centre for Addiction and Mental Health.
Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
UPMC Late-Life Depression, Evaluation, Prevention, and Treatment Program has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UPMC Late-Life Depression, Evaluation, Prevention, and Treatment Program has 3 clinical trials on record. Their work covers Treatment Resistant Depression, Refractory Depression, Therapy-Resistant Depression.
UPMC Late-Life Depression, Evaluation, Prevention, and Treatment Program has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.